54gene Funding & Investors
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
54gene.comTotal Amount Raised: $94,725,000
54gene Funding Rounds
Convertible Note
$50,000,000
Convertible Note Investors
Cathay InnovationIngressive CapitalPlexo CapitalBossa Nova InvestimentosAdjuvant CapitalEndeavor CatalystKdT VenturesSeries B
$25,000,000
Series B Investors
Cathay InnovationPlexo CapitalIngressive CapitalBossa Nova InvestimentosBienville CapitalEndeavor CatalystAdjuvant CapitalKdT VenturesDiverse AngelsAngel
$75,000
Angel Investors
Daniel SchryerSeries A
$15,000,000
Series A Investors
Ingressive CapitalPioneer FundAdjuvant CapitalY CombinatorAera VCKdT VenturesFifty YearsRaba PartnershipBetter VenturesV8 Capital PartnersSeed
$4,500,000
Seed Investors
Pioneer FundErik PetersonTechammerHack VCGabriel JarrossonY CombinatorAera VCFifty YearsKdT VenturesBetter VenturesMicrotractionSeed
$150,000
Seed Investors
Y Combinator
Funding info provided by Diffbot.